Common Reasons for Drug Noncompliance in Patients Who Are Attending Outpatient Clinics in Prince Mansur Military Hospital, Taif

Naif A Alzahrani^1, , Hassan Ali Alshehri², Alaa M Alwagdani¹, Bassam A Alzaidi¹, Wejdan M Safar³, Abdulelah Abdulrahman A⁴ and Faris Ghazi Almatrafi⁵

¹Family Medicine Resident, Taif, Saudi Arabian

²Lecturer, medical college, Taif University, Saudi Arabian

³General Practitioner, Alhada military hospital, Taif, Saudi Arabian

⁴4th year medical student at Taif University, Saudi Arabian

⁵4th year pharmacy student at Umm Al Qura University, Saudi Arabian

Cite this paper:
Naif A Alzahrani, Hassan Ali Alshehri, Alaa M Alwagdani, Bassam A Alzaidi, Wejdan M Safar, Abdulelah Abdulrahman A and Faris Ghazi Almatrafi. Common Reasons for Drug Noncompliance in Patients Who Are Attending Outpatient Clinics in Prince Mansur Military Hospital, Taif. American Journal of Medical Sciences and Medicine. 2020; 8(3):85-97. doi: 10.12691/ajmsm-8-3-1

Abstract

Background: Barriers to medication adherence in patients can have significant differences that made researchers confute to conclude that medication adherence is required to be more explored, and then, beneficial interventions develop to decrease these barriers. Some of the main barriers to patient compliance with pharmacological therapy the barriers to medication adherence included four concepts, namely, lifestyle challenges, patient incompatibility, forgetting of medicine use, and no expert advice. These concepts are always present in the disease process and reduce the patients' efforts to achieve normal living and adhere to the medication. Medication non-adherence when patients do not take their medications as prescribed is unfortunately fairly common, especially among patients with chronic disease. Most non-adherence is intentional patients make a rational decision not to take their medicine based on their knowledge, experience and beliefs there are many reasons for non-compliance with in patients for medication. Barriers to medication adherence in patients can have significant differences that made researchers confute to conclude that medication adherence is required to be more explored, and then, beneficial interventions develop to decrease these barriers. Aim of the study: To investigate the reasons of drug noncompliance among patients who are attending out patients clinics in Prince Mansur military hospital. Method: Cross sectional study conducted at outpatient clinics in Prince Mansur military hospital, Taif city. Sample population consists of Saudi out patients aged 20-70 years attending to outpatient clinics in Prince Mansur military hospital. Our total participants were (250). Results: Majority of the study suffer from chronic diseases (82.3%) the Diabetes, hypertension, high fat and cholesterol were their percentage was respectively (54.7%, 48.6% and 31.2%) not heave chronic diseases (17.7%). Conclusion: There are numerous studies on Common reasons for drug noncompliance in patients over the years the factors related to compliance may be better categorized as factors as the approach in countering their effects may differ. The study also highlights that the interaction of the various factors has not been studied systematically. Future studies need to address this interaction issue, as this may be crucial to reducing the level of non-compliance in general, and to enhancing the possibility of achieving the desired healthcare outcomes. Drug noncompliance not only includes patient compliance with medication but many factors for example also with diet, exercise, or life style changes.

Keywords:
common reasons drug noncompliance patients attending outpatient clinics hospital

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Assiri, T., Khurshid, F., Almutairi, M., Alhusayyen, M., Alkharji, F., & Alsultan, M. (2017). Impact of pharmacist intervention in patient counseling at point of hospital discharge in a specialized cardiac center in Saudi Arabia. Tropical Journal of Pharmaceutical Research, 16(5), 1187-1193.‏
[2]	El-Shamaa, E. T. (2013). Factors contributing to therapeutic compliance of epileptic patients and the suggestive solutions. Journal of Biology, Agriculture and Healthcare, 3(3), 22-35.‏
[3]	Kshirsagar, A. V., Hogan, S. L., Mandelkehr, L., & Falk, R. J. (2000). Length of stay and costs for hospitalized hemodialysis patients: nephrologists versus internists. Journal of the American Society of Nephrology, 11(8), 1526-1533.‏
[4]	George, D., Supramaniam, N. D., Abd Hamid, S. Q., Hassali, M. A., Lim, W. Y., & Hss, A. S. (2019). Effectiveness of a pharmacist-led quality improvement program to reduce medication errors during hospital discharge. Pharmacy Practice (Granada), 17(3).‏
[5]	Nieuwenhuis, M. M., Jaarsma, T., van Veldhuisen, D. J., Postmus, D., & van der Wal, M. H. (2012). Long-term compliance with nonpharmacologic treatment of patients with heart failure. The American journal of cardiology, 110(3), 392-397.‏
[6]	Yu, Z. L., Yeoh, L. Y., Seow, Y. Y., Luo, X. C., & Griva, K. (2012). Evaluation of adherence and depression among patients on peritoneal dialysis. Singapore Med J, 53(7), 474-480.‏
[7]	Lam, L. W., Twinn, S. F., & Chan, S. W. (2010). Self‐reported adherence to a therapeutic regimen among patients undergoing continuous ambulatory peritoneal dialysis. Journal of advanced nursing, 66(4), 763-773.‏
[8]	Bailey, D. L., Holden, M. A., Foster, N. E., Quicke, J. G., Haywood, K. L., & Bishop, A. (2020). Defining adherence to therapeutic exercise for musculoskeletal pain: a systematic review. British journal of sports medicine, 54(6), 326-331.‏
[9]	Loghman-Adham, M. (2003). Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation. American Journal of Managed Care, 9(2), 155-173.‏
[10]	Robin, A. L., Novack, G. D., Covert, D. W., Crockett, R. S., & Marcic, T. S. (2007). Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. American journal of ophthalmology, 144(4), 533-540.‏
[11]	Khan, A. R., Lateef, Z. N. A. A., Al Aithan, M. A., Bu-Khamseen, M. A., Al Ibrahim, I., & Khan, S. A. (2012). Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. Journal of Family and Community Medicine, 19(1), 26.‏
[12]	Naqvi, A. A., Al-Shayban, D. M., Ghori, S. A., Haseeb, A., Faidah, H. S., Mahmoud, M. A., & Hassali, M. A. (2019). Validation of the General Medication Adherence Scale (GMAS) in Saudi patients with chronic disease. Frontiers in pharmacology, 10, 633.‏
[13]	Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England journal of medicine, 353(5), 487-497.‏
[14]	Ramalingam, S., Pollak, K. I., Zullig, L. L., & Harrison, M. R. (2015). What should we tell patients about physical activity after a prostate cancer diagnosis?. Oncology, 29(9).‏
[15]	Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England journal of medicine, 353(5), 487-497.‏
[16]	OBoyle, S., Power, J., Ibrahim, M. Y., & Watson, J. (2002). Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). The International Journal of Tuberculosis and Lung Disease, 6(4), 307-312.‏
[17]	American Diabetes Association. (2013). Standards of medical care in diabetes—2013. Diabetes care, 36(Supplement 1), S11-S66.‏
[18]	Chironda, G., & Bhengu, B. (2016). Contributing factors to non-adherence among chronic kidney disease (CKD) patients: a systematic review of literature. Medical & Clinical Reviews, 2(4), 29.‏
[19]	Bosworth, H. B., Fortmann, S. P., Kuntz, J., Zullig, L. L., Mendys, P., Safford, M., ... & Rumptz, M. H. (2017). Recommendations for providers on person-centered approaches to assess and improve medication adherence. Journal of general internal medicine, 32(1), 93-100.‏
[20]	Touchette, D. R., & Shapiro, N. L. (2008). Medication compliance, adherence, and persistence: current status of behavioral and educational interventions to improve outcomes. J Manag Care Pharm, 14(6), S2-S10.‏
[21]	Rubin, R. R. (2005). Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. The American journal of medicine, 118(5), 27-34.‏
[22]	Ahmed, N., Abdul Khaliq, M., Shah, S. H., & Anwar, W. (2008). Compliance to antihypertensive drugs, salt restriction, exercise and control of systemic hypertension in hypertensive patients at
[23]	Billups, S. J., Malone, D. C., & Carter, B. L. (2000). The relationship between drug therapy noncompliance and patient characteristics, health‐related quality of life, and health care costs. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 20(8), 941-949.‏Abbottabad. J Ayub Med Coll Abbottabad, 20(2), 66-9.‏
[24]	Joho, A. A. (2012). Factors affecting treatment compliance among hypertension patients in three DISTRICT hospitals-dar es salaam (Doctoral dissertation, Muhimbili University of Health and Allied Sciences).‏
[25]	Kleinsinger, F. (2010). Working with the noncompliant patient. The Permanente Journal, 14(1), 54.‏